5G cloud-based check-up for heart device patients
Part of Cancer, Heart & circulation clinical trials.
This study tests whether a 5G-based remote check-up (over the cloud) is safe and effective for people with certain implanted heart devices, like pacemakers. You'll skip your first clinic visit and instead use a video call or remote check to see how your device is doing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a pacemaker, implantable defibrillator, or CRT device, but not a heart monitor.
- You haven't yet had your very first in-person check-up after getting the device.
- You are willing to sign a consent form and complete the study.
- You do not have a serious illness or mental condition that would make it hard to follow up.
- You are expected to live at least one year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people who have a heart device (like a pacemaker) to learn how these devices work in real life and how they affect patients. By joining, you help doctors improve care for future patients.
This study tests a heart failure alert system called HeartInsight in people who recently received an ICD or CRT-D device. The goal is to see if the alerts help doctors manage care better. You may qualify if you got a new (not replacement) device less than a year ago.
This trial tests whether remote monitoring of your implanted heart device can help your doctors better manage your heart failure. It is for people with certain types of pacemakers or defibrillators who are willing to share their device data remotely.
This study tests whether a special monitoring system in your heart device (called HeartLogic) can help detect early warning signs of heart failure getting worse. It uses wireless check-ins to track your condition at home and alert your doctor if you need help.
This study checks how well specific MicroPort CRM heart devices and leads work in real life over time. If you already have one of these FDA/market-approved implants and can be followed yearly, the study helps the company monitor safety and performance.
This study is testing a new type of implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) called the CorSky Family. The goal is to see how well it works for people who need a device to help their heart pump properly and prevent dangerous rhythms.
Hear when a new Sick Sinus Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.